MyAverix Finance
F · Healthcare
Jiangsu Recbio Technology Co., Ltd. (G93)
Biotechnology
Jiangsu Recbio Technology Co., Ltd. (G93) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $222.47M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for G93
Jiangsu Recbio Technology Co., Ltd. (G93) — FAQ
What is Jiangsu Recbio Technology Co., Ltd.'s market cap?
Jiangsu Recbio Technology Co., Ltd. (G93) has a reported market cap of $222.47M (data as of 2026-03-29).
What is G93's P/E ratio?
The price-to-earnings (P/E) ratio for Jiangsu Recbio Technology Co., Ltd. (G93) is 18.00 (data as of 2026-03-29).
Does Jiangsu Recbio Technology Co., Ltd. pay a dividend?
Dividend yield is not available in the current snapshot for Jiangsu Recbio Technology Co., Ltd. (G93). Check the MyAverix Finance app for the latest dividend data.
What sector is Jiangsu Recbio Technology Co., Ltd. in?
Jiangsu Recbio Technology Co., Ltd. (G93) is classified in the Healthcare sector (Biotechnology industry).
What exchange is G93 listed on?
G93 is listed on F.
What is Jiangsu Recbio Technology Co., Ltd.'s net margin?
Jiangsu Recbio Technology Co., Ltd. (G93) reports a net margin of 0.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.